Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis

Journal of Pharmacology and Pharmacotherapeutics

Volumn 5, Issue 1, 2014, Pages 76-78

  Goel, Divya ^a  

^a MAHARISHI MARKANDESHWAR INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Bedaquiline; multiple drug resistant tuberculosis; tuberculosis

Indexed keywords

BEDAQUILINE; TM 207; UNCLASSIFIED DRUG;

ACNE; ARTICLE; DIARRHEA; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEARING IMPAIRMENT; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; PAIN; THORAX PAIN; VIRUS INFECTION;

EID: 84892762434     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.124435     Document Type: Article

References (17)

1. World Health Organization. Global Tuberculosis Report 2012. Geneva, Switzerland: WHO; 2012. Available from: http://www.who.int/tb/publications/ global-report/en. [Accessed on 2012 Dec 15].
2. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosis. Lancet 2010;375:1830-43.
3. Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008;178:1075-82.
4. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2009. Geneva, Switzerland: WHO; 2009.
5. Totally drug-resistant TB emerges in India. Discovery of a deadly form of TB highlights crisis of 'mismanagement', 2012 Jan 13 Available from: http://www.nature.com/news/totally-drug-resistant-tb-emerges-in-ind ia-1.9797. [Accessed on 2013 Jun 25].
6. Stop TB. Partnership. The Global Plan to Stop TB, 2006-2015: Actions for Life: Towards a World Free of Tuberculosis. Geneva: WHO; 2006. Available from: http://www.stoptb.org/global/plan. [Accessed on 2013 May 25].
7. Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005;307:223-7.
8. Koul A, Vranckx L, Dendouga N, Balemans W, Van den Wyngaert I, Vergauwen K, et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 2008;283:25273-80.
9. Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 2007;3:323-4.
10. Haagsma AC, Abdillahi-Ibrahim R, Wagner MJ, Krab K, Vergauwen K, Guillemont J, et al. Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue. Antimicrob Agents Chemother 2009;53:1290-2.
11. Rustomjee R, Diacon AH, Allen J, Venter A, Reddy C, Patientia RF, et al. Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis. Antimicrob Agents Chemother 2008;52:2831-5.
12. Diacon AH, Donald PR, Pym A, Grobusch M, Patientia RF, Mahanyele R, et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: Long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother 2012;56:3271-6.
13. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009;360:2397-405.
14. 42nd Union World Conference on Lung Health in Lille, France,Clinical trials of new drugs and regimens for MDR- and XDR-TB, 2011. Available from: http://www.worldlunghealth.org/confLille/images/stories/PDF- Symposias/Symposium-46.pdf. [Accessed on 2013 Jan 25].
15. FDA approves first drug to treat multi-drug resistant tuberculosis. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm333695.htm. [Accessed on 2013 Jan 5].
16. Lounis N, Gevers T, Van Den Berg J, Andries K. Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model. Antimicrob Agents Chemother 2008;52:3568-72.
17. India Government approves bedaquiline for resistant TB on fill-in basis, 2013 Mar 11 Available from: http://www.elsevierbi.com/publications/pharmasia- news/Article #28130310001. [Accessed on 2013 Mar 25].